Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 4:00 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 73–96 of 349 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Long-term outcomes Clear all

Conditions: Multiple Sclerosis
Interventions: Treadmill-integrated virtual reality gait training; Other
Lead sponsor: Shepherd Center, Atlanta GA; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Hepatitis
Interventions: Emapalumab; Drug
Lead sponsor: Children's Healthcare of Atlanta; Other
Eligibility: 1 Year to 30 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Primary Biliary Cholangitis
Interventions: Saroglitazar magnesium 1 mg, Placebo; Drug
Lead sponsor: Zydus Therapeutics Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 386 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 3
States / cities: Marietta, Georgia • Indianapolis, Indiana • Houston, Texas

Conditions: Burn
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 1 Day to 21 Years
Enrollment: 3,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2000 – 2013
U.S. locations: 4
States / cities: Sacramento, California • Boston, Massachusetts • Cincinnati, Ohio + 1 more

Conditions: Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment
Interventions: management of therapy complications, psychosocial assessment and care; Procedure
Lead sponsor: Children's Oncology Group; Network
Eligibility: 6 Years to 16 Years
Enrollment: 286 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2011
U.S. locations: 31
States / cities: Phoenix, Arizona • Loma Linda, California • Long Beach, California + 26 more

Conditions: Cardiovascular Disease, Hematologic Diseases, Immunologic Disease, Cancer, Respiratory Function
Interventions: Not listed
Lead sponsor: National Institute of Environmental Health Sciences (NIEHS); NIH
Eligibility: 21 Years and older
Enrollment: 32,658 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2011
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Osteoarthritis
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 20 Years to 75 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Critically Ill Very Elderly Patients Admitted to ICU's
Interventions: Not listed
Lead sponsor: St. Luke's-Roosevelt Hospital Center; Other
Eligibility: 65 Years and older
Enrollment: 399 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: New York, New York

Conditions: Pulmonary Hypertension, Sickle Cell Disease
Interventions: Not listed
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 18 Years to 99 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Metastatic Non-small Cell Lung Cancer
Interventions: nivolumab + ipilimumab; Biological
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 18 Years and older
Enrollment: 103 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Dublin, Ohio

Conditions: Achrochordon
Interventions: Digiclamp (Skin tag removal initial plus follow-up); Device
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Ocala, Florida

Conditions: Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms
Interventions: dutasteride; Drug
Lead sponsor: Urology of Virginia; Other
Eligibility: 50 Years and older · Male only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 2
States / cities: Norfolk, Virginia • Virginia Beach, Virginia

Conditions: Opioid-use Disorder, Opioid Use, Unspecified, Buprenorphine Dependence
Interventions: Subutex / Buprenorphine, Fetal & Neonatal MRI, DNA/Genetic/Pharmacokenetic Blood Draws; Drug · Diagnostic Test
Lead sponsor: Senthil Sadhasivam; Other
Eligibility: 18 Years and older · Female only
Enrollment: 600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2026
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Uterine Fibroid
Interventions: NA- no intervention; Other
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older · Female only
Enrollment: 700 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 4
States / cities: San Francisco, California • Detroit, Michigan • Rochester, Minnesota + 1 more

Conditions: HIV Infection, Liver Transplant
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 2
States / cities: Baltimore, Maryland • New York, New York

Conditions: Temporomandibular Joint and Muscle Disorder
Interventions: Biobehavioral, Active Coping/Attention Intervention; Behavioral
Lead sponsor: The University of Texas at Arlington; Other
Eligibility: 18 Years and older
Enrollment: 456 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Arlington, Texas

Conditions: Ulcerative Colitis, Pediatric, Inflammatory Bowel Diseases, Crohn Disease
Interventions: Not listed
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 1 Year to 18 Years
Enrollment: 1,100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 4
States / cities: Chapel Hill, North Carolina • Charlotte, North Carolina • Durham, North Carolina + 1 more

Conditions: Metabolic Syndrome
Interventions: Beetroot Juice - Active, beetroot juice - Placebo; Drug
Lead sponsor: Penn State University; Other
Eligibility: 55 Years to 75 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Weight Loss, Obesity, Aging
Interventions: Not listed
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 60 Years and older
Enrollment: 588 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Common Femoral Artery Stenosis, Calcification; Heart
Interventions: Shockwave Catheter, CFA Endarterectomy; Device · Procedure
Lead sponsor: Baylor Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Plano, Texas

Conditions: Osteoarthritis, Hip
Interventions: KINCISE, Traditional Handheld Mallet; Device
Lead sponsor: University of Cincinnati; Other
Eligibility: 21 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Substance Use, Adolescent Behavior
Interventions: Parenting Wisely+, Treatment as Usual; Behavioral
Lead sponsor: Brown University; Other
Eligibility: 12 Years to 17 Years
Enrollment: 122 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 2
States / cities: Rockford, Illinois • Cranston, Rhode Island

Conditions: Anterior Knee Pain Syndrome
Interventions: Knee Isometric Program (KIP); Behavioral
Lead sponsor: The Methodist Hospital Research Institute; Other
Eligibility: 18 Years to 65 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Tobacco Use Cessation, Perioperative/Postoperative Complications, Tobacco Smoking
Interventions: Brief behavioral intervention, SMS Program; Behavioral · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Rochester, Minnesota

Search by objective public record fields.

Investigating the Impact of Treadmill-integrated Virtual Reality Training on Walking Outside the Clinic

Severe Hepatitis Intervention With Emapalumab for Liver Disease

Long-Term Study to Evaluate the Safety and Efficacy in Participants With Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes

Multicenter Benchmarking of Functional and Psychosocial Outcomes of Pediatric Burn Survivors

Neurobehavioral Complications in Children Who Were Previously Treated With Steroids and Intrathecal Therapy for Acute Lymphoblastic Leukemia

Gulf Long-Term Follow-Up Study

Outcomes of Robotic Total Hip Arthroplasty

Treatment Intensity/Factors Predicting Short and Long Term Outcomes in Elderly Critically Ill Patients

Phosphodiesterase Type-5 Inhibitor Therapy in Sickle Cell People With Pulmonary Hypertension

Long-term Outcomes Among Patients With Programmed Death-ligand 1 <1% Metastatic Non-small Cell Lung Cancer Treated With First-line Nivolumab + Ipilimumab + 2 Cycles of Chemotherapy

Study to Evaluate the Efficacy of Removing Skin Tags With Digiclamp

Dutasteride for Improving Peri-Operative and Long-Term Outcomes of Photoselective Vaporization of the Prostate (DOP)

Opioid Use Disorder in Pregnancy in Long-Term Maternal/Infant Outcomes

Ascertaining Longterm Outcomes of Fibroid Treatments

Expanding HOPE Liver

An Implementation and Biobehavioral Study of Temporomandibular Joint and Muscle Disorder (TMJMD)

COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)

Nitrate Supplementation and Cerebrovascular and Cognitive Function in Metabolic Syndrome

Health Outcomes After Participating in Exercise (HOPE)

Shockwave™ vs Surgical Endarterectomy for Calcified Severe Common Femoral Artery Stenosis: Comparison of Efficacy, Safety and Long-Term Outcomes

KINCISE™ Surgical Automated System in Total Hip Arthroplasty (THA)

Adolescents With Substance Use Disorders Transitioníng From Residential Treatment to the Community

Knee Isometric Program (KIP) Home Exercise Programs (HEP) Physical Therapy (PT) Study

Short Messaging Service Program to Help Quit Smoking During Perioperative Period.